Drs. Charles Ryan and Alicia Morgans - 10/20/2021

Dr. Ryan is a Professor of Medicine in the Division of Hematology, Oncoogy and Transplantation at the University of Minnesota.

Research interests: My research focuses on the development of novel therapies for patients with advanced and recurrent prostate cancer. In particular, I have focused on new hormonal and targeted therapies for prostate cancer, as well as the biomarkers that define aggressiveness of disease and response to treatment. I also lead projects related to the cognitive effects of prostate cancer therapies and the role of exercise and lifestyle and their effect on patients with prostate cancer.

My clinical interests: My clinical work is focused on patients with all genitourinary cancers with a particular focus on prostate cancer and testicular cancer

There is an interview with Dr. Ryan in September 2021's issue of Prostatepedia where he talks about Chemotherapy and Genomics. Click here to goto this issue of Prostatepedia and scroll down to the second aritcle.

Educational interests: I mentor many trainees and faculty in the development of research strategies related to genitourinary cancers.


  • Clinical Trials
  • Hormonal Therapy for prostate cancer
  • Therapy development for prostate cancer
  • Treatment of advanced testicular cancer
  • Cancer survivorship
  • Exercise and Cancer

Professional Associations

American Society of Clinical Oncology

  • American Association for Ethical Research
  • Alliance for Clinical Trials in Oncology
  • National Comprehensive Cancer Network
  • Prostate Cancer Foundation
  • American Joint Committee on Cancer
  • Movember Foundation
  • NCI/GUSC Prostate Cancer Task Force

Research Summary/Interests

  • Cancer
  • Urologic Oncology
  • Prostate Cancer
  • Clinical Trials
  • Hormonal Therapy
  • Secondary Hormonal Therapy
  • Insulin-like Growth Factor Receptor
  • Androgen Receptor
  • Adrenal Androgens
  • Angiogenesis Inhibitors
  • Testicular Cancer
  • Germ Cell Neoplasm
  • Human Research Subject Protection
  • Research Ethics

Research Funding Grants

  • Prostate Cancer Foundation Challenge Award
  • NIH National Cancer Institute Cancer Center Support Grant
  • NIH National Cancer Institute Serum Androgens Grant
  • Alliance (CALGB) Grant
  • American Association for Cancer Research Grant


Academic Interests and Focus

My on campus teaching involves case based training and teaching in the medical oncology clinic as well as within the Hematology/Oncology Fellowship Program.


Board Certifications

  • Medical Oncology

Clinical Interests

All genitourinary cancers with a particular focus on prostate cancer and testicular cancer.

Alicia Morgans is a Genitourinary Medical Oncologist and the Medical Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported outcome measures, as well as incorporating patient preferences and beliefs into clinical decision making. Her research has investigated complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications. Her work has been funded by grants from the Prostate Cancer Foundation and the Department of Defense. She is a member of the advanced and localized prostate cancer treatment guidelines committee of the American Urologic Association, and is a member of the cardio-oncology committee of the American Heart Association. Since 2016, she has been President of the Medical Advisory Board for ZERO, a non-profit organization dedicated to supporting education and research funding for prostate cancer research.

Board Certification:

  • Medical Oncology, 2012


  • Dana-Farber Cancer Institute / Massachusetts General Hospital


  • Hospital of the University of Pennsylvania

Medical School:

  • University of Pennsylvania, Perelman School of Medicine

Clinical Interests

  • Cancer survivorship
  • Quality of life
  • Shared decision making


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215

Videos of Interest:

Recognizing and Managing the Side Effects of Androgen Deprivation Therapy

Treatment Options and Emerging Concepts